RecruitingNCT04914026

MicroRNA as Markers in Testicular Cancer

MicroRNA-371 as Markers for Disease Activity and as a Tool to Monitor the Effect of Chemotherapy and Early Detection of Recurrence in Patients With Testicular Germ Cell Tumours


Sponsor

Haukeland University Hospital

Enrollment

350 participants

Start Date

Dec 31, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

The main objective of this study is establish the performance of miR371 in management of testicular cancer


Eligibility

Sex: MALEMin Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at whether tiny molecules called microRNAs found in the blood can be used as reliable markers to detect and monitor testicular cancer, potentially making diagnosis and follow-up easier and less invasive. **You may be eligible if:** - You have a suspected testicular cancer and are scheduled for surgery to remove the testicle - You have been diagnosed with testicular germ cell cancer - You are between 18 and 70 years old - You are able to understand the study information and give consent **You may NOT be eligible if:** - You have another cancer (other than testicular cancer) either currently or in the past - You have other medical or mental health conditions that would prevent you from participating in follow-up visits Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBiomarker analysis

Blood collection. Blood samples will be collected at diagnosis, during surveillance, during treatment and every 3-6 months


Locations(6)

Haukeland University Hospital

Bergen, Norway

Haugesund Hospital

Haugesund, Norway

Oslo University Hospital

Oslo, Norway

University Hospital of North Norway

Tromsø, Norway

Sahlgrenska University Hospital

Gothenburg, Sweden

Karolinska University Hospital

Stockholm, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04914026


Related Trials